Akanda (AKAN) has the highest short interest by a US stock in the Biotechnology Industry, with 124.02% of float sold short (903,214 shares).
| ASSET | SHARES SHORT | FLOAT | SHORT % OF FLOAT | SHORT RATIO |
|---|---|---|---|---|
Akanda (AKAN) | 903,214 | 656,871 | 124.02% | .16 |
Biodexa Pharmaceticals (BDRX) | 494,378 | 61.3185B | 72.51% | .25 |
Pasithea Therapeutics (KTTA) | 452,180 | 5.9241M | 51.85% | .21 |
Tectonic Therapeutic (TECX) | 5.3532M | 12.121M | 50.32% | 17.84 |
Acrivon Therapeutics, Inc Common Stock (ACRV) | 5.1217M | 16.857M | 42.87% | 10.19 |
Arcturus Therapeutics (ARCT) | 7.7065M | 26.273M | 40.94% | 8.91 |
LENZ Therapeutics (LENZ) | 7.1735M | 20.0521M | 39.48% | 6.12 |
Intellia Therapeutics (NTLA) | 40.5783M | 110.1959M | 39.3% | 9.39 |
AnaptysBio (ANAB) | 5.6442M | 14.4215M | 38.69% | 10.19 |
Sana Biotechnology (SANA) | 37.7643M | 176.9683M | 38.66% | 7 |
aTyr Pharma (ATYR) | 30.3855M | 95.5506M | 37.09% | 11.92 |
ARS Pharmaceuticals (SPRY) | 21.5882M | 105.4062M | 35.58% | 10.04 |
Replimune (REPL) | 14.7615M | 52.8464M | 35.19% | 8.52 |
Kalvista Pharmaceuticals (KALV) | 15.3877M | 29.9486M | 34.25% | 9.82 |
Immunitybio (IBRX) | 109.0244M | 336.3754M | 32.95% | 9 |
Monopar Therapeutics (MNPR) | 822,858 | 4.228M | 32.88% | 5.22 |
Iovance Biotherapeutics (IOVA) | 120.3428M | 338.6533M | 32.71% | 12.26 |
Novavax (NVAX) | 52.5905M | 134.8757M | 32.48% | 15.17 |
Purple Biotech (PPBT) | 600,079 | 508.6304M | 31.66% | .16 |
Recursion Pharmaceuticals (RXRX) | 153.7387M | 504.0193M | 31.29% | 7.31 |
Summit Therapeutics (SMMT) | 35.7537M | 124.7834M | 30.19% | 14.04 |
Syndax Pharmaceuticals (SNDX) | 22.8261M | 73.277M | 29.62% | 10.84 |
Tango Therapeutics (TNGX) | 33.5499M | 80.1601M | 28.88% | 12.54 |
Sellas Life Sciences (SLS) | 40.4666M | 141.7499M | 28.62% | 8.67 |
Neurogene (NGNE) | 3.5387M | 5.2101M | 28.39% | 17.44 |
Historical short interest data is not available.
